{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:45:39Z","timestamp":1788972339184,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11864-015-0387-8","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T06:46:18Z","timestamp":1453963578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Management of Hyperleukocytosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Antonio","family":"Ruggiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"387_CR1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.1987.5.9.1364","volume":"5","author":"JP Dutcher","year":"1987","unstructured":"Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol. 1987;5:1364\u201372.","journal-title":"J Clin Oncol"},{"key":"387_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009053534","volume":"39","author":"P Porcu","year":"2000","unstructured":"Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, et al. Hyperleukocytic leukemias: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39:1\u201318.","journal-title":"Leuk Lymphoma"},{"key":"387_CR3","first-page":"1070","volume-title":"Hematology: basic principles and practice","author":"SL Berg","year":"2000","unstructured":"Berg SL, Steuber CP, Poplack DG. Clinical manifestations of acute lymphocytic leukemia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, editors. Hematology: basic principles and practice. 3rd ed. New York: Churchill Livingstone; 2000. p. 1070\u20138.","edition":"3"},{"issue":"5","key":"387_CR4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjh.13189","volume":"168","author":"N Daver","year":"2015","unstructured":"Daver N, Kantarjian H, Marcucci G, Pierce S, Brandt M, Dinardo C, et al. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis. J Haematol. 2015;168(5):646\u201353. This study demonstrates that leukapheresis does not improve the outcomes in patients with APL presenting with hyperleucocytosis.","journal-title":"J Haematol"},{"issue":"1","key":"387_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0889-8588(18)30262-4","volume":"7","author":"TM Lestingi","year":"1993","unstructured":"Lestingi TM, Hooberman AL. Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 1993;7(1):161\u201375.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"387_CR6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005792-197411000-00006","volume":"53","author":"LC McKee Jr","year":"1974","unstructured":"McKee Jr LC, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine. 1974;53(6):463\u201378.","journal-title":"Medicine"},{"issue":"2","key":"387_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI107191","volume":"52","author":"MA Lichtman","year":"1973","unstructured":"Lichtman MA et al. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations. J Clin Invest. 1973;52(2):350\u20138.","journal-title":"J Clin Invest"},{"issue":"12","key":"387_CR8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1200\/JCO.1985.3.12.1590","volume":"3","author":"NJ Bunin","year":"1985","unstructured":"Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol. 1985;3(12):1590\u20135.","journal-title":"J Clin Oncol"},{"key":"387_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V38.3.299.299","volume":"38","author":"MH Steinberg","year":"1971","unstructured":"Steinberg MH, Charm SE. Effect of high concentrations of leukocytes on whole blood viscosity. Blood. 1971;38:229\u2013301.","journal-title":"Blood"},{"issue":"7","key":"387_CR10","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","volume":"97","author":"A Stucki","year":"2001","unstructured":"Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97(7):2121\u20139.","journal-title":"Blood"},{"issue":"26","key":"387_CR11","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1200\/JCO.2011.36.2756","volume":"29","author":"E Piro","year":"2011","unstructured":"Piro E, Carillio G, Levato L, Kropp M, Molica S. Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia. J Clin Oncol. 2011;29(26):e725\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"387_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.blre.2012.01.003","volume":"26","author":"C Ganzel","year":"2012","unstructured":"Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26(3):117\u201322. In the current article the technical aspects, complications and efficacy of leukapheresis are discussed.","journal-title":"Blood Rev"},{"issue":"10","key":"387_CR13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/JCO.1989.7.10.1528","volume":"7","author":"JW Karesh","year":"1989","unstructured":"Karesh JW, Goldman EJ, Reck K, Kelman SE, Lee EJ, Schiffer CA. A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings. J Clin Oncol. 1989;7(10):1528\u201332.","journal-title":"J Clin Oncol"},{"key":"387_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00043426-199608000-00022","volume":"18","author":"JC Murray","year":"1989","unstructured":"Murray JC, Dorfman SR, Brandt ML, Dreyer ZE. Renal vein thrombosis complicating acute myeloid leukemia with hyperleukocytosis. J Pediatr Hematol Oncol. 1989;18:327\u201330.","journal-title":"J Pediatr Hematol Oncol"},{"key":"387_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.2830460320","volume":"46","author":"R Mataix","year":"1994","unstructured":"Mataix R, Gomez-Casares MT, Campo C, Jimanez S, Malcorra JJ. Acute leg ischemia as a presentation of hyperleukocytosis syndrome in acute myeloid leukemia. Am J Hematol. 1994;46:250\u20131.","journal-title":"Am J Hematol"},{"issue":"2","key":"387_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960050435","volume":"19","author":"JR Kerr","year":"2000","unstructured":"Kerr JR, Matthews RC. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis. 2000;19(2):77\u201388.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"387_CR17","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V93.8.2730","volume":"93","author":"M Nakagawa","year":"1999","unstructured":"Nakagawa M, Bondy GP, Waisman D, Minshall D, Hogg JC, van Eeden SF. The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood. 1999;93(8):2730\u20137.","journal-title":"Blood"},{"issue":"5","key":"387_CR18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","volume":"169","author":"GL Jones","year":"2015","unstructured":"Jones GL, Will A, Jackson GH, Webb NJ, Rule S, British Committee for Standards in Haematology. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2015;169(5):661\u201371. This work provides the guidelines for the management of patients with tumour lysis syndrome (TLS), reviewed by the British Committee for Standards in Haematology.","journal-title":"Br J Haematol"},{"issue":"12","key":"387_CR19","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3324\/haematol.13290","volume":"93","author":"P Tosi","year":"2008","unstructured":"Tosi P, Barosi G, Lazzaro C, Liso V, Marchetti M, Morra E, et al. Consensus conference on the management of tumor lysis syndrome. Haematologica. 2008;93(12):1877\u201385.","journal-title":"Haematologica"},{"issue":"8","key":"387_CR20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12325-011-0041-1","volume":"28","author":"A Pession","year":"2011","unstructured":"Pession A, Masetti R, Gaidano G, Tosi P, Rosti G, Aglietta M, et al. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel. Adv Ther. 2011;28(8):684\u201397.","journal-title":"Adv Ther"},{"issue":"5","key":"387_CR21","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1172\/JCI108700","volume":"59","author":"JD Conger","year":"1977","unstructured":"Conger JD, Falk SA. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest. 1977;59(5):786\u201393.","journal-title":"J Clin Invest"},{"issue":"16","key":"387_CR22","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767\u201378.","journal-title":"J Clin Oncol"},{"issue":"3","key":"387_CR23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1076029607302435","volume":"13","author":"A Dixit","year":"2007","unstructured":"Dixit A, Chatterjee T, Mishra P, Kannan M, Choudhry DR, Mahapatra M, et al. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Clin Appl Thromb Hemost. 2007;13(3):292\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"387_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG, British Committee for Standards in Haematology. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24\u201333.","journal-title":"Br J Haematol"},{"issue":"3","key":"387_CR25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1521-6926(03)00057-4","volume":"16","author":"G Avvisati","year":"2003","unstructured":"Avvisati G, Tallman MS. All-trans retinoic acid in acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16(3):419\u201332.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"21","key":"387_CR26","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C R\u00f6llig","year":"2015","unstructured":"R\u00f6llig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood. 2015;125(21):3246\u201352. Based on facts and considerations about hyperleukocytosis, the study suggests a treatment algorithm for this condition in patients affected by AML. The aim is to provide useful and rapid tools for the admitting physician to prevent early death.","journal-title":"Blood"},{"issue":"21","key":"387_CR27","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.89.21.9991","volume":"89","author":"BN Cronstein","year":"1992","unstructured":"Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992;89(21):9991\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"387_CR28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jcb.24394","volume":"114","author":"WH Tsai","year":"2013","unstructured":"Tsai WH, Lai SL, Li IT, Chien HY, Shih CH, Kou YR, et al. Annexin A1 mediates the anti-adhesive effects of the dexamethasone-treated promyelocytic leukemic cells. J Cell Biochem. 2013;114(3):551\u20137. The paper shows how dexamethasone enhances the release of factors which can prevent the adhesion of the trans-retinoic acid (ATRA) treated acute promyelocytic leukemic (APL) cells to endothelial cells.","journal-title":"J Cell Biochem"},{"issue":"4","key":"387_CR29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2014.01.004","volume":"38","author":"S Oberoi","year":"2014","unstructured":"Oberoi S, Lehrnbecher T, Phillips B, Hitzler J, Ethier MC, Beyene J, et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res. 2014;38(4):460\u20138. This study investigates the role of leukapheresis and low-dose chemotherapy in decreasing early mortality in acute myeloid leukemia (AML) patients with hyperleukocytosis. It seems that early mortality related to hyperleukocytosis in AML is not influenced either by leukapheresis or by hydroxyurea\/low-dose chemotherapy.","journal-title":"Leuk Res"},{"key":"387_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pbc.21562","volume":"51","author":"GD Cuvelier","year":"2008","unstructured":"Cuvelier GD, Vitali AM, Ford JC, Dix DB. Multiple intracranial tumors in Philadelphia chromosome positive acute lymphoblastic leukemia: successful treatment following aggressive supportive care, early cranial radiation, high dose chemotherapy and imatinib. Pediatr Blood Cancer. 2008;51:135\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"387_CR31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jfma.2014.01.006","volume":"113","author":"KH Chen","year":"2014","unstructured":"Chen KH, Liu HC, Liang DC, Hou JY, Huang TH, Chang CY, et al. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis. J Formos Med Assoc. 2014;113:833\u20138.","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"387_CR32","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/0883073808318201","volume":"23","author":"MK Koenig","year":"2008","unstructured":"Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol. 2008;23(11):1347\u201352.","journal-title":"J Child Neurol"},{"issue":"12","key":"387_CR33","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1200\/JCO.1994.12.12.2621","volume":"12","author":"RW Butler","year":"1994","unstructured":"Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol. 1994;12(12):2621\u20139.","journal-title":"J Clin Oncol"},{"issue":"25","key":"387_CR34","first-page":"2730","volume":"360","author":"CH Pui","year":"2009","unstructured":"Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(25):2730\u201341.","journal-title":"N Engl J Med"},{"issue":"1","key":"387_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1526-0968.2002.00402.x","volume":"6","author":"P Porcu","year":"2002","unstructured":"Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher. 2002;6(1):15\u201323.","journal-title":"Ther Apher"},{"issue":"2","key":"387_CR36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2141.1997.1943011.x","volume":"98","author":"P Porcu","year":"1997","unstructured":"Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol. 1997;98(2):433\u20136.","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"387_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109097677","volume":"42","author":"FJ Giles","year":"2001","unstructured":"Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O\u2019Brien S, Anderlini P, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma. 2001;42(1\u20132):67\u201373.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"387_CR38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1200\/JCO.1988.6.9.1425","volume":"6","author":"HS Maurer","year":"1988","unstructured":"Maurer HS, Steinherz PG, Gaynon PS, Finklestein JZ, Sather HN, Reaman GH, et al. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol. 1988;6(9):1425\u201332.","journal-title":"J Clin Oncol"},{"issue":"1","key":"387_CR39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12185-009-0333-2","volume":"90","author":"A Ruggiero","year":"2009","unstructured":"Ruggiero A, Attin\u00e0 G, Piastra M, Maurizi P, Mastrangelo S, Pietrini D, et al. Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. Int J Hematol. 2009;90(1):87\u201390.","journal-title":"Int J Hematol"},{"issue":"4","key":"387_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-2007-976170","volume":"33","author":"W Blum","year":"2007","unstructured":"Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost. 2007;33(4):350\u20134.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"387_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1526-0968.2003.00035.x","volume":"7","author":"B Stegmayr","year":"2003","unstructured":"Stegmayr B, Wikdahl AM. Access in therapeutic apheresis. Ther Apher Dial. 2003;7(2):209\u201314.","journal-title":"Ther Apher Dial"},{"issue":"2","key":"387_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1537-2995.1989.29289146829.x","volume":"29","author":"DM Sutton","year":"1989","unstructured":"Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion. 1989;29(2):124\u20137.","journal-title":"Transfusion"},{"issue":"1","key":"387_CR43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1744-9987.2009.00716.x","volume":"14","author":"PS Malchesky","year":"2010","unstructured":"Malchesky PS, Koo AP, Skibinski CI, et al. Apheresis technologies and clinical applications: the 2007 International Apheresis Registry. Ther Apher Dial. 2010;14(1):52\u201373.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"387_CR44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/107327481502200109","volume":"22","author":"LS Connelly-Smith","year":"2015","unstructured":"Connelly-Smith LS, Linenberger ML. Therapeutic apheresis for patients with cancer. Cancer Control. 2015;22(1):60\u201378. This paper documents the efficacy and limitations of therapeutic apheresis (TA) for the treatment of certain disease complications in patients with cancer. It contains the expert-based practice guidelines from the American Society for Apheresis, including clinical adverse events of TA, to support clinical decision-making for malignancy-related complications.","journal-title":"Cancer Control"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-015-0387-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0387-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T13:32:06Z","timestamp":1600090326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-015-0387-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s11864-015-0387-8","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]},"article-number":"7"}}